AMPK: an emerging drug target for diabetes and the metabolic syndrome.
about
Insulin sensitizing effects of oligomannuronate-chromium (III) complexes in C2C12 skeletal muscle cellsModulation of de novo purine biosynthesis leads to activation of AMPK and results in improved glucose handling and insulin sensitivityStructural bases of PAS domain-regulated kinase (PASK) activation in the absence of activation loop phosphorylationRecent advances in understanding the anti-diabetic actions of dietary flavonoidsThe AMPK signalling pathway coordinates cell growth, autophagy and metabolismEndoplasmic reticulum stress and the inflammatory basis of metabolic diseaseHydroxycinnamic acid derivatives: a potential class of natural compounds for the management of lipid metabolism and obesityAMPK as a potential anticancer target - friend or foe?Metabolic reprogramming by class I and II histone deacetylasesSignal transductions and nonalcoholic fatty liver: a mini-reviewImpaired hypothalamic mTOR activation in the adult rat offspring born to mothers fed a low-protein dietADP Regulates SNF1, the Saccharomyces cerevisiae Homolog of AMP-Activated Protein KinaseThe Influence of the Gut Microbiota on Host Physiology: In Pursuit of MechanismsBeneficial role of bitter melon supplementation in obesity and related complications in metabolic syndromeLong-term supplementation with a cystine-based antioxidant delays loss of muscle mass in agingPKC-dependent human monocyte adhesion requires AMPK and Syk activationCardiovascular disease-related parameters and oxidative stress in SHROB rats, a model for metabolic syndromeEffects of puerarin on lipid accumulation and metabolism in high-fat diet-fed miceTang-Nai-Kang alleviates pre-diabetes and metabolic disorders and induces a gene expression switch toward fatty acid oxidation in SHR.Cg-Leprcp/NDmcr ratsAmpelopsin Improves Insulin Resistance by Activating PPARγ and Subsequently Up-Regulating FGF21-AMPK Signaling PathwayOral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunctionGlutathione S-transferases interact with AMP-activated protein kinase: evidence for S-glutathionylation and activation in vitroSuppression of 5'-nucleotidase enzymes promotes AMP-activated protein kinase (AMPK) phosphorylation and metabolism in human and mouse skeletal muscleAdipose tissue deficiency and chronic inflammation in diabetic Goto-Kakizaki ratsRibosomal protein S6 kinase 1 signaling regulates mammalian life spanLITAF and TNFSF15, two downstream targets of AMPK, exert inhibitory effects on tumor growthVoluntary Exercise Improves Estrous Cyclicity in Prenatally Androgenized Female Mice Despite Programming Decreased Voluntary Exercise: Implications for Polycystic Ovary Syndrome (PCOS).Specific biomarkers for stochastic division patterns and starvation-induced quiescence under limited glucose levels in fission yeast.Effects of a wheat bran extract containing arabinoxylan oligosaccharides on gastrointestinal health parameters in healthy adult human volunteers: a double-blind, randomised, placebo-controlled, cross-over trial.Purification, crystallization and preliminary crystallographic analysis of protein MJ1225 from Methanocaldococcus jannaschii, a putative archaeal homologue of gamma-AMPKDevelopment of novel adenosine monophosphate-activated protein kinase activators.Effects of turmeric curcuminoids and metformin against central sensitivity to pain in mice.Adenosine monophosphate kinase activator α-lipoic acid: A promising therapeutic agent for metabolic syndrome?Differential roles of the glycogen-binding domains of beta subunits in regulation of the Snf1 kinase complexIdentification of AMPK activator from twelve pure compounds isolated from Aralia Taibaiensis: implication in antihyperglycemic and hypolipidemic activities.Metformin alters DNA methylation genome-wide via the H19/SAHH axisPodocyte Autophagy: A Potential Therapeutic Target to Prevent the Progression of Diabetic NephropathyIn silico design for adenosine monophosphate-activated protein kinase agonist from traditional chinese medicine for treatment of metabolic syndromes.Protectin DX ameliorates palmitate- or high-fat diet-induced insulin resistance and inflammation through an AMPK-PPARα-dependent pathway in miceNovel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-β peptide degradation.
P2860
Q21135221-B2E37529-7657-4057-9FFA-B429BE0037F2Q21195699-280B1285-2548-4EF5-B943-E5D94E64ABF7Q24302557-4A021F64-A761-4902-8380-18A82493008CQ24601195-7FB4D862-CC0B-40EE-9AE9-6D5DB21C20FCQ24616273-DEEE0D01-D429-4E68-96F0-74741ED6535AQ24633352-4A878914-E9B1-47EB-8FDD-6705087C5CD0Q26749072-31F1B779-22C0-434A-BD58-394319896863Q26829427-E9FD223D-3A1A-4BDD-B219-DDC982278931Q26860745-043906DE-7887-467D-88CE-30748BA4B20CQ26991757-91293CF0-2F4A-4A3E-89DF-160028A7902CQ27305995-6EEF0FFC-4DBE-48B1-807E-905D86CB6524Q27675159-1A001B52-0CB0-468F-B0EB-AFF8288C17C3Q28070162-5B72AC90-8D56-43E3-897E-C7FDA006D770Q28081950-E6244323-CB08-4BDC-88C7-FB2195F6374BQ28384001-4161A934-793E-49A6-BDFD-90A2626BDFD5Q28481555-3F24A433-B713-4E49-9B49-6903237BBC78Q28541804-F0E79DF0-214F-489D-9A88-F1A67AA51A13Q28545151-1F737EF3-4B81-4A01-84A9-EA20A1116B82Q28546258-C3709E1C-C44A-47D5-9AD0-F3F19B56F7F5Q28552475-D2334DAC-132F-4509-A5AD-37423F7B81DAQ28569684-2EACE9AC-1401-4290-A64E-5AE0D189B70BQ28578663-207535FC-91A2-4424-911E-E1BB0071E0C8Q28584878-D8CDA599-C2EF-4B6D-A15C-BCA621AEFF39Q28742364-8A5060A8-AD69-4C2E-9D27-DB2E88839A1AQ29615975-F36AA018-A875-47FB-AFD4-8F342C1F580CQ30179387-CA735A64-E990-4014-AC0B-D59E137FA9CAQ30355011-97AC2662-B398-4CFC-94C8-A05899AC33C5Q30501631-01D7BA6F-6A11-428E-B5DC-4785538202C8Q33453517-ED8236F0-0856-4399-9A79-9B2A05648050Q33490081-ABF8ABDE-F158-466C-BD1A-299682C7FEC9Q33532741-846B303B-981C-40C6-8048-204128FBCBAAQ33552951-892CCE3D-5364-4B50-B141-7B66E4730387Q33585815-988ADDC5-D64A-49F4-AFC8-C89F10A526E9Q33585891-C712E275-BE3C-4ADB-B1FC-517F31A4701BQ33614734-C731E293-BD21-4511-9AA6-1E1627B549EDQ33635268-67BA24CD-DC38-4DDA-AFAD-55DFF444360FQ33645471-F8C53D31-0CDE-4373-8609-8CF8961788F8Q33668408-6543865D-EC6D-495D-8235-1DE84068F169Q33683986-DE4C5BDD-EDEA-4FBB-B468-5DF998C0FCC5Q33695751-96FA95CC-5438-4408-BAA8-BABE0226B0F4
P2860
AMPK: an emerging drug target for diabetes and the metabolic syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
AMPK: an emerging drug target for diabetes and the metabolic syndrome.
@en
AMPK: an emerging drug target for diabetes and the metabolic syndrome.
@nl
type
label
AMPK: an emerging drug target for diabetes and the metabolic syndrome.
@en
AMPK: an emerging drug target for diabetes and the metabolic syndrome.
@nl
prefLabel
AMPK: an emerging drug target for diabetes and the metabolic syndrome.
@en
AMPK: an emerging drug target for diabetes and the metabolic syndrome.
@nl
P2093
P1433
P1476
AMPK: an emerging drug target for diabetes and the metabolic syndrome.
@en
P2093
P304
P356
10.1016/J.CMET.2009.03.012
P577
2009-05-01T00:00:00Z